by John Conrad | Nov 17, 2025 | iBIO News
Even with Washington hitting the pause button during the federal shutdown, this month’s GBG Report still surfaced 78 new non-dilutive funding opportunities, notices of special interest, and RFIs across the life sciences landscape. That’s a slimmer number than usual —...
by John Conrad | Jun 6, 2024 | NewsBrief
The biopharma sector has undergone significant changes in venture funding and investment trends during the first quarter of 2024, according to a recent PitchBook report. Despite a decrease in deal count, the sector saw an increase in venture funding, with $7.4 billion...
by John Conrad | Jun 4, 2024 | iBIO News
The biotech industry is facing a stark contrast between the robust state of scientific innovation and the challenging financial and economic environment, according to the latest EY Beyond Borders reportEY Beyond Borders report. While exciting advancements continue in...
